Casey Harpole, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 916 W Monroe Ave, Lowell, AR 72745 Phone: 479-751-3764 |
John Lykins, PD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 114 Harrison Ave, Lowell, AR 72745 Phone: 479-770-0111 Fax: 479-770-0113 |
Mitchell Padgett Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 916 W Monroe Ave, Lowell, AR 72745 Phone: 479-751-3764 |
Derek Messmer, PD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 114 Harrison Ave, Lowell, AR 72745 Phone: 479-770-0111 Fax: 479-770-0113 |
News Archive
Elan Corporation, plc and Transition Therapeutics, Inc today announced the results of a Phase 2 placebo-controlled study in 351 patients with mild to moderate Alzheimer's disease who received study drug for up to 18 months (Study AD201). Study subjects with MMSE scores between 16 and 26 received ELND005 oral doses of 250 mg, 1000 mg or 2000 mg twice daily or matching placebo. The study's cognitive (NTB) and functional (ADCS-ADL) co - primary endpoints did not achieve statistical significance.
New research from the University of Copenhagen points to an entirely new approach for designing insulin-based pharmaceuticals. The approach could open the door for more personalized medications with fewer side effects for Type 1 Diabetes patients.
Aiming to relaunch the nation's patient safety agenda with renewed energy and focus, the Institute for Healthcare Improvement today hosts representatives from 24 organizations to begin work on a national strategy for reducing harm in the delivery of health care.
As theories about autism spread like wildfire in the media and the general public, a panel of autism experts will reflect on the validity of four widely held - and potentially inaccurate - assumptions about the developmental disability.
› Verified 5 days ago